Intensity Therapeutics, Inc. (INTS) Balance Sheet

NASDAQ: INTSAssets, liabilities, debt and equity over 7 years.

INTS balance sheet, 2025

December 31, 2025 · U.S. dollars

$14.1M assets = $2.2M liabilities + $11.9M equity

What it owns$14.1MCash & ST investments: $11.9M (84.5%)Cash & ST investments$11.9M · 85%Other current: $788,000 (5.6%)PP&E: $96,000 (0.7%)Other non-current: $1.3M (9.2%)Other non-current $1.3M=How it is financed$14.1MCurrent liabilities: $2.1M (15.2%)Current liabilities$2.1M · 15%Other LT liabilities: $79,000 (0.6%)Shareholders’ equity: $11.9M (84.2%)Shareholders’ equity$11.9M · 84%

Both columns are drawn to the same scale: what INTS owns equals what it owes plus shareholders’ equity. Hover a block for its value.

INTS financial health

Current ratio5.92
Comfortable · current assets cover current liabilities 5.92×
Debt / equity0.01
Low leverage · $0.01 of debt for each $1 of equity
Equity / assets84.2%
Equity-funded · of assets funded by shareholders
Cash / debt10,837.3%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

INTS balance sheet trends, 2019–2025

Intensity Therapeutics, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$9.0M2019$14.1M2025+7.8%/yr
Total liabilities$1.3M2019$2.2M2025+9.3%/yr
Shareholders’ equity$7.7M2019$11.9M2025+7.5%/yr
Cash & short-term investments$8.4M2019$11.9M2025+6.0%/yr
Total debt$260,2702019$110,0002025−13.4%/yr
Net cash (debt)$8.1M2019$11.8M2025+$3.7M
Working capital$7.5M2019$10.6M2025+$3.0M
Current ratio7.6720195.922025−1.74
Debt / equity0.0320190.012025−0.02

Change is the average annual growth (CAGR) or the difference between the first and latest year.

INTS assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

INTS liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

INTS debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

INTS balance sheet

Intensity Therapeutics, Inc. annual balance sheet
2025202420232022202120202019
Assets
Cash & short-term investments$11.9M$2.6M$14.8M$1.3M$4.5M$9.3M$8.4M
Cash & equivalents$11.9M$2.6M$8.6M$1.3M$4.5M$9.3M$3.8M
Short-term investments—$0$6.2M$0—$0$4.6M
Receivables$0$0$0$62,304$51,262$48,521$33,634
Inventory$0$0$0$29,359$70,444$217,174$205,468
Other current assets$788,000$773,000$688,000$47,337$69,282$0$16,472
Total current assets$12.7M$3.4M$15.5M$1.5M$4.7M$9.5M$8.6M
Property, plant & equipment (net)$96,000$122,000$147,000$139,000$318,126$490,240$252,668
Goodwill & intangible assets$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0
Other non-current assets$1.3M$1.3M$1.7M$167,000$167,738$181,703$104,441
Total assets$14.1M$4.8M$17.3M$1.8M$5.2M$10.1M$9.0M
Liabilities
Accounts payable$583,000$1.2M$3.0M$603,000$172,508$222,707$393,963
Short-term debt$31,000$28,000$20,000$4.5M$2.2M$171,226$117,194
Total current liabilities$2.1M$1.8M$4.0M$6.8M$3.7M$1.3M$1.1M
Long-term debt$0$0$0$0$0$0$0
Lease obligations$110,000$138,000$158,000$143,221$325,907$497,481$260,270
Other long-term liabilities$79,000$110,000$174,000$10.0M$10.2M$10.4M$179,076
Total liabilities$2.2M$1.9M$4.1M$16.9M$13.9M$11.7M$1.3M
Shareholders' equity
Common stock & paid-in capital—$2,000$1,000$341$341$682$681
Retained earnings (deficit)−$78.4M−$66.8M−$50.5M−$38.7M−$31.1M−$23.2M−$17.1M
Accumulated other comprehensive income——−$17.3M—−$31.1M−$23.2M−$17.1M
Total shareholders' equity$11.9M$2.9M$13.2M−$15.1M−$8.7M−$1.6M$7.7M
Key figures
Total debt$110,000$138,000$158,000$4.5M$2.3M$497,481$260,270
Net cash (debt)$11.8M$2.5M$14.6M−$3.2M$2.2M$8.8M$8.1M
Working capital$10.6M$1.6M$11.5M−$5.4M$1.0M$8.1M$7.5M
Tangible book value$11.9M$2.9M$13.2M−$15.1M−$8.7M−$1.6M$7.7M
Book value per share$8.76——————
Shares outstanding1.4M——————
Current ratio5.921.923.910.211.277.047.67
Quick ratio5.551.483.730.201.236.967.47
Debt / equity0.010.050.01———0.03
Equity / assets84.2%61.0%76.1%−859.3%−166.5%−15.4%85.5%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 27, 2026); data from EODHD.

INTS financial position

At the end of fiscal 2025 (December 31, 2025), Intensity Therapeutics had total assets of $14.1 million (up 194.8% from a year earlier), total liabilities of $2.2 million and shareholders' equity of $11.9 million. It held $11.9 million in cash and short-term investments against $0.1 million of debt, a net cash position of $11.8 million. Its current ratio was 5.92. In the latest quarter (ended June 30, 2026) total assets were $11.5 million and equity $9.2 million.

Related: INTS income statement, INTS cash flow statement, INTS key metrics. See the INTS stock overview for the latest quote and news.

INTS balance sheet FAQ

What are Intensity Therapeutics's total assets?

Intensity Therapeutics reported total assets of $14.1 million at the end of fiscal 2025 (December 31, 2025), compared with $4.8 million a year earlier.

How much debt does Intensity Therapeutics have?

Intensity Therapeutics had $0.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.01.

How much cash does Intensity Therapeutics have?

Intensity Therapeutics held $11.9 million in cash and short-term investments at the end of fiscal 2025; with $0.1 million of debt that is net cash of $11.8 million.

What is Intensity Therapeutics's book value?

Intensity Therapeutics's shareholders' equity (book value) was $11.9 million at the end of fiscal 2025, or $8.76 per share.

What is Intensity Therapeutics's current ratio?

Intensity Therapeutics had current assets of $12.7 million and current liabilities of $2.1 million, a current ratio of 5.92 (it can cover its short-term obligations).

Biotechnology: balance sheet